Frequency Therapeutics Valuation
| KRRO Stock | 54.99 1.74 3.27% |
At this time, the firm appears to be undervalued. Frequency Therapeutics shows a prevailing Real Value of USD67.84 per share. The current price of the firm is USD54.99. Our model computes the value of Frequency Therapeutics from reviewing the firm fundamentals such as Current Valuation of 419.95 M, shares owned by insiders of 6.44 %, and Number Of Shares Shorted of 244.85 K as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Frequency Therapeutics' valuation include:
Price Book 2.8679 | Enterprise Value 419.9 M | Enterprise Value Ebitda (5.60) |
Undervalued
Today
Please note that Frequency Therapeutics' price fluctuation is not too volatile at this time. Calculation of the real value of Frequency Therapeutics is based on 3 months time horizon. Increasing Frequency Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Frequency Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Frequency Stock. However, Frequency Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 54.99 | Real 67.84 | Target 116.67 | Hype 46.54 |
The intrinsic value of Frequency Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Frequency Therapeutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Frequency Therapeutics helps investors to forecast how Frequency stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Frequency Therapeutics more accurately as focusing exclusively on Frequency Therapeutics' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Frequency Therapeutics' intrinsic value based on its ongoing forecasts of Frequency Therapeutics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Frequency Therapeutics' closest peers.
Frequency Therapeutics Cash |
|
Frequency Valuation Trend
Knowing Frequency Therapeutics' actual value is paramount for traders when making sound investment determinations. Using both Frequency Therapeutics' enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Frequency Valuation Data Drivers
Frequency Therapeutics Total Value Analysis
Frequency Therapeutics is now projected to have valuation of 419.95 M with market capitalization of 515.16 M, debt of 33.21 M, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Frequency Therapeutics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
419.95 M | 515.16 M | 33.21 M |
Frequency Therapeutics Asset Utilization
One of the ways to look at asset utilization of Frequency is to check how much profit was generated for every dollar of assets it reports. Frequency Therapeutics shows a negative utilization of assets of -0.35 percent, losing USD0.003527 for each dollar of assets held by the firm. Inadequate asset utilization denotes the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Frequency Therapeutics shows how discouraging it operates for each dollar spent on its assets.Frequency Therapeutics Ownership Allocation
The market capitalization of Frequency Therapeutics is USD515.16 Million. The majority of Frequency Therapeutics outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Frequency Therapeutics to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Frequency Therapeutics. Please pay attention to any change in the institutional holdings of Frequency Therapeutics as this could imply that something significant has changed or is about to change at the company. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.Frequency Therapeutics Profitability Analysis
Net Loss for the year was (81.17 M) with profit before overhead, payroll, taxes, and interest of 0.About Frequency Therapeutics Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Frequency Therapeutics. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Frequency Therapeutics based exclusively on its fundamental and basic technical indicators. By analyzing Frequency Therapeutics's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Frequency Therapeutics's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Frequency Therapeutics. We calculate exposure to Frequency Therapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Frequency Therapeutics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -3.6 M | -3.4 M | |
| Pretax Profit Margin | (1.79) | (1.88) | |
| Operating Profit Margin | (2.90) | (3.05) | |
| Net Loss | (1.80) | (1.88) | |
| Gross Profit Margin | 0.65 | 0.56 |
Frequency Therapeutics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 1.5 M |
Frequency Therapeutics Current Valuation Indicators
Frequency Therapeutics' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Frequency Therapeutics' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Frequency Therapeutics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Frequency Therapeutics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Frequency Therapeutics' worth.When determining whether Frequency Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Frequency Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Frequency Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Frequency Therapeutics Stock: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Frequency Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Frequency Stock, please use our How to Invest in Frequency Therapeutics guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Frequency Therapeutics. If investors know Frequency will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Frequency Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.43) | Return On Assets (0.35) | Return On Equity (0.75) |
The market value of Frequency Therapeutics is measured differently than its book value, which is the value of Frequency that is recorded on the company's balance sheet. Investors also form their own opinion of Frequency Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Frequency Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Frequency Therapeutics' market value can be influenced by many factors that don't directly affect Frequency Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Frequency Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Frequency Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Frequency Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.